no key · no human

Cancernetwork API, RSS and sitemap

Every article Cancernetwork publishes, as JSON, through an open API with no key and no signup. 745 of their articles are indexed right now, refreshed hourly.

#7,257 by volume

Four ways to pull cancernetwork.com

All four are ours, all four are live, and none of them needs a key.

JSON Search this publisher

Every article we hold from cancernetwork.com, newest first. Add q= to search inside.

curl -s "https://freenewsapi.ai/v1/search?host=www.cancernetwork.com&size=20"open it →

RSS Subscribe in any reader

The same articles as an RSS 2.0 feed. Works in Feedly, Inoreader, Thunderbird — anywhere.

curl -s "https://freenewsapi.ai/v1/rss?host=www.cancernetwork.com&size=50"open it →

JSON Feed For apps

JSON Feed 1.1, the same content in a format apps parse natively.

curl -s "https://freenewsapi.ai/v1/feed.json?host=www.cancernetwork.com&size=50"open it →

Trimmed For agents

Only the fields an agent needs — title, url, date, language — so the response stays small.

curl -s "https://freenewsapi.ai/v1/search?host=www.cancernetwork.com&size=20&fields=title,url,published_at,lang"open it →

What this outlet covers, by share of its recent output:

health 100%

Call the API

A live request. Paste it into a terminal and Cancernetwork headlines come back as JSON.

bash
curl "https://freenewsapi.ai/v1/search?host=www.cancernetwork.com&size=5"
745
articles indexed
291
in the last 30 days
9
median per day
0
languages
812 min
median crawl lag
23.08 → 20.09
archive depth

Publishing volume

Articles per day over the last 25 days. The busiest hour is 12:00 UTC — that is when the newsroom pushes its main batch.

2026-08-23: 2 articles2026-08-24: 8 articles2026-08-25: 10 articles2026-08-26: 13 articles2026-08-27: 16 articles2026-08-28: 30 articles2026-08-29: 4 articles2026-08-30: 3 articles2026-08-31: 14 articles2026-09-01: 19 articles2026-09-02: 25 articles2026-09-03: 16 articles2026-09-04: 24 articles2026-09-05: 4 articles2026-09-06: 4 articles2026-09-10: 8 articles2026-09-11: 9 articles2026-09-12: 2 articles2026-09-14: 8 articles2026-09-15: 8 articles2026-09-16: 20 articles2026-09-17: 22 articles2026-09-18: 16 articles2026-09-19: 4 articles2026-09-20: 2 articles08-2308-2708-3109-0409-1109-1609-20
bash
curl "https://freenewsapi.ai/v1/stats?host=www.cancernetwork.com&top=10"

Publishing rhythm

When Cancernetwork actually publishes, by hour of day (UTC) and by day of week — measured from 745 timestamps, not from a schedule they advertise.

00: 20001: 00102: 00203: 00304: 00405: 00506: 00607: 00708: 00809: 00910: 01011: 01112: 641213: 71314: 561415: 191516: 301617: 181718: 401819: 101920: 262021: 102122: 92223: 023
Mon: 30MonTue: 37TueWed: 58WedThu: 62ThuFri: 79FriSat: 14SatSun: 11Sun

Latest articles

The 18 most recent Cancernetwork articles in the index — the same rows the API returns, rendered for humans.

<![CDATA[Key Takeaways for Multidisciplinary Lung Cancer Care From WCLC 2026]]>
2026-09-20 14:00 UTC
<![CDATA[Poster sessions at WCLC 2026 detail how surgery, nursing, and pathology can contribute to the multidisciplinary care of patients with lung cancer.]]>
<![CDATA[Pembrolizumab/Enfortumab Vedotin Earns Positive CHMP Opinion in MIBC]]>
2026-09-19 16:00 UTC
<![CDATA[A positive CHMP opinion supports the perioperative use of pembrolizumab plus enfortumab vedotin in resectable MIBC regardless of cisplatin eligibility.]]>
<![CDATA[Screening for CHIP Mutations to Guide CAR T Cell Candidacy in Lymphoma]]>
2026-09-19 14:00 UTC
<![CDATA[Jasmine Zain, MD, described how pre-existing CHIP mutations should inform pre-infusion risk counseling and treatment selection.]]>
<![CDATA[Japan Approves T-DXd Combo and Dato-DXd for First-Line Metastatic Breast Cancer]]>
2026-09-18 19:00 UTC
<![CDATA[T-DXd and Dato-DXd are now approved treatments in Japan for patients with breast cancer. ]]>
<![CDATA[FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer]]>
2026-09-18 18:05 UTC
<![CDATA[Data from the phase 3 EMBER-3 trial support the full approval of imlunestrant plus abemaciclib in this breast cancer population.]]>
<![CDATA[Fixed-Duration Combinations and MRD-Guided Therapy as Emerging Priorities in CLL]]>
2026-09-18 18:00 UTC
<![CDATA["Patients [with cancer] and physicians would rather have a fixed-duration treatment, if possible," said Julie M. Vose, MD, MBA, at SOHO 2026.]]>
<![CDATA[NCCN Guidelines Strengthen MRD Testing Recommendations in Multiple Myeloma]]>
2026-09-18 15:30 UTC
<![CDATA[Updated NCCN Guidelines for multiple myeloma add a dedicated MRD testing framework and expand recommended MRD assessment timepoints.]]>
<![CDATA[Relacorilant Combo Receives Positive CHMP Opinion in Ovarian Cancer]]>
2026-09-18 14:30 UTC
<![CDATA[The European Medicines Agency’s CHMP recommended approval of relacorilant plus nab-paclitaxel for platinum-resistant ovarian cancer based on the ROSELLA trial.]]
<![CDATA[SOHO 2026: Disparities, Efficacy, and Long-Term Safety in B-Cell Lymphoma]]>
2026-09-18 14:00 UTC
<![CDATA[Posters highlighted sex-based differences in aggressive B-cell NHL, third-line therapies in aggressive BCL, and real-world safety with CD20/CD3 bispecifics.]]>
<![CDATA[NICE Recommends T-DXd for HER2-Low Metastatic Breast Cancer]]>
2026-09-18 13:00 UTC
<![CDATA[NICE recommended trastuzumab deruxtecan for reimbursement in England for HER2-low metastatic breast cancer, backed by DESTINY-Breast04 data.]]>
<![CDATA[Subcutaneous Amivantamab Combo is a “Clear” New Standard in EGFR+ NSCLC]]>
2026-09-18 12:00 UTC
<![CDATA[Subcutaneous amivantamab is safer and more convenient for patients compared with the intravenous formulation, according to Misako Nagasaka, MD, PhD.]]>
<![CDATA[Navigating Transplant Strategy for Partial Responders in T-Cell Lymphoma]]>
2026-09-17 22:00 UTC
<![CDATA[Mary Jo Lechowicz, MD, discussed how pre-transplant depth of response informs the choice between autologous and allogeneic HSCT in T-cell lymphoma.]]>
<![CDATA[Differentiating Mutagenesis From Genotoxic Risk in Secondary Malignancies]]>
2026-09-17 20:00 UTC
<![CDATA[Jasmine Zain, MD, described the molecular workup to determine whether a secondary malignancy after CAR T-cell therapy reflects direct insertional mutagenesis.]]>
<![CDATA[SOHO 2026: Novel Frontline Strategies and Molecular Approaches in Lymphoma]]>
2026-09-17 18:00 UTC
<![CDATA[SOHO 2026 sessions covered chemoimmunotherapy in frontline DLBCL, treatment selection via molecular classifiers, and bispecific antibodies for unfit patients.]]>
<![CDATA[FDA Clears Triton Robotic Endoscopy System for Colon Procedures]]>
2026-09-17 17:00 UTC
<![CDATA[The FDA cleared the Triton 1 robotic endoscopy system for diagnostic and therapeutic procedures such as colorectal cancer screening and lesion removal.]]>
<![CDATA[ASTRO Issues First Clinical Practice Guideline on Radiation for Bladder Cancer]]>
2026-09-17 16:00 UTC
<![CDATA[ASTRO’s first standalone clinical practice guideline for bladder cancer recommends trimodal therapy vs radical cystectomy for select muscle-invasive disease case
<![CDATA[PD-1/VEGF Bispecific Antibody Receives FDA Fast Track Designation in NSCLC]]>
2026-09-17 15:30 UTC
<![CDATA[Investigators are evaluating cesalatamig among patients with advanced cancer in the international phase 1/2 BiPAVE-001 trial.]]>
<![CDATA[KST-6051 Receives FDA Fast Track Designation in KRAS-Mutant Solid Tumors]]>
2026-09-17 14:00 UTC
<![CDATA[The FDA granted fast track designation to the oral pan-KRAS inhibitor KST-6051 for patients with KRAS-mutant advanced or metastatic solid tumors.]]>

Harvest it all

Page through the archive by date. from and to accept YYYY-MM-DD or relative values such as now-7d.

bash
curl "https://freenewsapi.ai/v1/search?host=www.cancernetwork.com&from=now-7d&size=100"

To poll for new material, keep the timestamp of the newest article you saw and ask only for what came after it:

bash
curl "https://freenewsapi.ai/v1/search?host=www.cancernetwork.com&from=now-1h&sort=date_asc"

Article bodies come with full_text=true. No key, no quota tier, no header — see the search endpoint for every parameter.

Metadata quality

How well Cancernetwork marks up its own pages — useful if you are deciding whether to parse them yourself.

0%
dates from JSON-LD
0%
articles with a byline
0%
articles with sections
—
average page weight

Crawl lag — the delay between publication and the article reaching this index — is 812 min at the median, 5471 minutes at the 90th percentile.

FAQ

Does Cancernetwork have an official API?

Not a public one. This endpoint is the practical alternative: their articles as structured JSON, with title, lead, publication time, section, byline and a link back to the original.

How do I get their RSS feed?

Most publishers expose one at /rss or /feed, but feeds carry only the last few dozen items and drop them within hours. This index keeps 745 of their articles and lets you filter by date, language and section.

How many articles does Cancernetwork publish per day?

9 on a median day, measured across 25 days.

Can I use this commercially?

The API is free and unauthenticated. What you may do with the content is between you and the publisher: we return metadata, a lead paragraph and a link, not a licence.